LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 130

Suchoptionen

  1. Buch: Neutral proteases of mast cells

    Schwartz, Lawrence B.

    15 tables

    (Monographs in allergy ; 27)

    1990  

    Verfasserangabe vol. ed. L. B. Schwartz
    Serientitel Monographs in allergy ; 27
    Überordnung
    Schlagwörter Mast Cells / enzymology ; Peptide Hydrolases / metabolism ; Mastzelle ; Proteasen
    Schlagwörter EC 3.4 ; Proteinasen ; Peptidasen ; Proteolytisches Enzym ; Peptid-Hydrolasen
    Umfang VIII, 165 S. : Ill., graph. Darst.
    Verlag Karger
    Erscheinungsort Basel u.a.
    Erscheinungsland Schweiz
    Dokumenttyp Buch
    HBZ-ID HT003748891
    ISBN 3-8055-5162-2 ; 978-3-8055-5162-5
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Kategorien

  2. Artikel ; Online: Heparin comes clean.

    Schwartz, Lawrence B

    The New England journal of medicine

    2008  Band 358, Heft 23, Seite(n) 2505–2509

    Mesh-Begriff(e) Animals ; China ; Chondroitin Sulfates/pharmacology ; Complement Activation/drug effects ; Complement C3a/biosynthesis ; Complement C3a/drug effects ; Complement C5a/biosynthesis ; Complement C5a/drug effects ; Drug Contamination ; Heparin/pharmacology ; Humans ; Hypotension/chemically induced ; Kallikreins/drug effects ; Kallikreins/metabolism ; Kininogens/drug effects ; Kininogens/metabolism
    Chemische Substanzen Kininogens ; Complement C3a (80295-42-7) ; Complement C5a (80295-54-1) ; Heparin (9005-49-6) ; Chondroitin Sulfates (9007-28-7) ; Kallikreins (EC 3.4.21.-)
    Sprache Englisch
    Erscheinungsdatum 2008-06-05
    Erscheinungsland United States
    Dokumenttyp Comment ; Editorial
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMe0803599
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptase.

    Lieberman, Phillip / Schwartz, Lawrence B

    The journal of allergy and clinical immunology. In practice

    2013  Band 1, Heft 3, Seite(n) 315

    Mesh-Begriff(e) Anaphylaxis/enzymology ; Anaphylaxis/immunology ; Anaphylaxis/pathology ; Animals ; Bites and Stings ; Humans ; Immunoglobulin E/biosynthesis ; Immunoglobulin E/blood ; Male ; Mast Cells/enzymology ; Mast Cells/immunology ; Mast Cells/pathology ; Mastocytosis/enzymology ; Mastocytosis/immunology ; Mastocytosis/pathology ; Middle Aged ; Risk Factors ; Severity of Illness Index ; Tryptases/biosynthesis ; Tryptases/blood ; Up-Regulation/immunology ; Wasp Venoms/adverse effects ; Wasp Venoms/immunology ; Wasps
    Chemische Substanzen Wasp Venoms ; Immunoglobulin E (37341-29-0) ; Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2013-05
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article ; Review
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2012.10.003
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Analysis of MC(T) and MC(TC) mast cells in tissue.

    Schwartz, Lawrence B

    Methods in molecular biology (Clifton, N.J.)

    2006  Band 315, Seite(n) 53–62

    Abstract: The MC(TC) and MCT types of human mast cells initially were recognized on the basis of the protease compositions of their secretory granules, with tryptase, chymase, carboxypeptidase A3, and cathepsin G in the former and only tryptase in the latter. ... ...

    Abstract The MC(TC) and MCT types of human mast cells initially were recognized on the basis of the protease compositions of their secretory granules, with tryptase, chymase, carboxypeptidase A3, and cathepsin G in the former and only tryptase in the latter. Antibodies against chymase and tryptase traditionally have been used to distinguish these mast cell types from one another. Antitryptase antibodies label all mast cells; antichymase labels only the MC(TC) type. To identify both types in a tissue section, a sequential double-labeling scheme was developed to first stain chymase-positive cells, thereby blocking their recognition by the antitryptase antibody, which will label only the chymase-negative mast cells. In general, these immunocytochemical techniques are more sensitive and specific than classical histochemical techniques for detecting mast cells.
    Mesh-Begriff(e) Biomarkers/analysis ; Cell Separation/methods ; Chymases ; Humans ; Immunohistochemistry/methods ; Mast Cells/chemistry ; Mast Cells/enzymology ; Mast Cells/immunology ; Mast Cells/ultrastructure ; Serine Endopeptidases/chemistry ; Serine Endopeptidases/metabolism ; Tryptases
    Chemische Substanzen Biomarkers ; Serine Endopeptidases (EC 3.4.21.-) ; Chymases (EC 3.4.21.39) ; Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2006
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 1064-3745
    ISSN 1064-3745
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Diagnostic value of tryptase in anaphylaxis and mastocytosis.

    Schwartz, Lawrence B

    Immunology and allergy clinics of North America

    2006  Band 26, Heft 3, Seite(n) 451–463

    Abstract: Serum (or plasma) levels of total and mature tryptase measurements are recommended in the diagnostic evaluation of systemic anaphylaxis and systemic mastocytosis, but their interpretation must be considered in the context of a complete workup of each ... ...

    Abstract Serum (or plasma) levels of total and mature tryptase measurements are recommended in the diagnostic evaluation of systemic anaphylaxis and systemic mastocytosis, but their interpretation must be considered in the context of a complete workup of each patient. Total tryptase levels generally reflect the increased burden of mast cells in patients with all forms of systemic mastocytosis (indolent systemic mastocytosis, smoldering systemic mastocytosis, systemic mastocytosis associated with a hematologic clonal non-mast cell disorder, aggressive systemic mastocytosis, and mast cell leukemia) and the decreased burden of mast cells associated with cytoreductive therapies in these disorders. Causes of an elevated total tryptase level other than systemic mastocytosis must be considered, however, and include systemic anaphylaxis, acute myelocytic leukemia, various myelodysplastic syndromes, hypereosinophilic syndrome associated with the FLP1L1-PDGFRA mutation, end-stage renal failure, and treatment of onchocerciasis. Mature (beta) tryptase levels generally reflect the magnitude of mast cell activation and are elevated during most cases of systemic anaphylaxis, particularly with parenteral exposure to the inciting agent.
    Mesh-Begriff(e) Anaphylaxis/blood ; Anaphylaxis/diagnosis ; Anaphylaxis/enzymology ; Animals ; Humans ; Mastocytosis/blood ; Mastocytosis/diagnosis ; Mastocytosis/enzymology ; Time Factors ; Tryptases/blood
    Chemische Substanzen Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2006-08
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 92606-1
    ISSN 1557-8607 ; 0889-8561
    ISSN (online) 1557-8607
    ISSN 0889-8561
    DOI 10.1016/j.iac.2006.05.010
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Clinical communication: systemic capillary leak syndrome due to mast cell activation?

    Van Winkle, Robert C / Malatack, J Jeffrey / Schwartz, Lawrence B / McGeady, Stephen J

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2019  Band 122, Heft 4, Seite(n) 428–429

    Mesh-Begriff(e) Anaphylaxis/blood ; Anaphylaxis/diagnosis ; Anaphylaxis/immunology ; Capillary Leak Syndrome/blood ; Capillary Leak Syndrome/diagnosis ; Capillary Leak Syndrome/immunology ; Child ; Diagnosis, Differential ; Humans ; Male ; Mast Cells/immunology ; Tryptases/blood
    Chemische Substanzen Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2019-01-09
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Letter
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2019.01.002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation.

    Dailey, Jordan M / Kee, Sydney A / Tharakan, Anuj / Kazi, Aslamuzzaman / Burchett, Jason R / Kolawole, Elizabeth Motunrayo / Boyd Ballance, William / Kotha, Aditya / Le, Quang T / Schwartz, Lawrence B / Straus, David B / Martin, Rebecca K / Sebti, Said M / Ryan, John J

    Journal of immunology (Baltimore, Md. : 1950)

    2023  Band 211, Heft 4, Seite(n) 527–538

    Abstract: IgE-mediated mast cell activation is a driving force in allergic disease in need of novel interventions. Statins, long used to lower serum cholesterol, have been shown in multiple large-cohort studies to reduce asthma severity. We previously found that ... ...

    Abstract IgE-mediated mast cell activation is a driving force in allergic disease in need of novel interventions. Statins, long used to lower serum cholesterol, have been shown in multiple large-cohort studies to reduce asthma severity. We previously found that statins inhibit IgE-induced mast cell function, but these effects varied widely among mouse strains and human donors, likely due to the upregulation of the statin target, 3-hydroxy-3-methylgutaryl-CoA reductase. Statin inhibition of mast cell function appeared to be mediated not by cholesterol reduction but by suppressing protein isoprenylation events that use cholesterol pathway intermediates. Therefore, we sought to circumvent statin resistance by targeting isoprenylation. Using genetic depletion of the isoprenylation enzymes farnesyltransferase and geranylgeranyl transferase 1 or their substrate K-Ras, we show a significant reduction in FcεRI-mediated degranulation and cytokine production. Furthermore, similar effects were observed with pharmacological inhibition with the dual farnesyltransferase and geranylgeranyl transferase 1 inhibitor FGTI-2734. Our data indicate that both transferases must be inhibited to reduce mast cell function and that K-Ras is a critical isoprenylation target. Importantly, FGTI-2734 was effective in vivo, suppressing mast cell-dependent anaphylaxis, allergic pulmonary inflammation, and airway hyperresponsiveness. Collectively, these findings suggest that K-Ras is among the isoprenylation substrates critical for FcεRI-induced mast cell function and reveal isoprenylation as a new means of targeting allergic disease.
    Mesh-Begriff(e) Mice ; Humans ; Animals ; Receptors, IgE/metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Farnesyltranstransferase/metabolism ; Mast Cells/metabolism ; Anaphylaxis/metabolism ; Signal Transduction ; Cell Degranulation ; Immunoglobulin E/metabolism ; Inflammation/metabolism ; Cholesterol/metabolism ; Prenylation
    Chemische Substanzen Receptors, IgE ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Farnesyltranstransferase (EC 2.5.1.29) ; Immunoglobulin E (37341-29-0) ; Cholesterol (97C5T2UQ7J)
    Sprache Englisch
    Erscheinungsdatum 2023-07-14
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.2200862
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Presence or absence of elevated acute total serum tryptase by itself is not a definitive marker for an allergic reaction.

    Sprung, Juraj / Weingarten, Toby N / Schwartz, Lawrence B

    Anesthesiology

    2015  Band 122, Heft 3, Seite(n) 713–714

    Mesh-Begriff(e) Anaphylaxis/diagnosis ; Anesthesia/adverse effects ; Drug Hypersensitivity/diagnosis ; Female ; Heart Arrest/diagnosis ; Histamine/blood ; Humans ; Male ; Shock/diagnosis ; Tryptases/blood
    Chemische Substanzen Histamine (820484N8I3) ; Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2015-03
    Erscheinungsland United States
    Dokumenttyp Comment ; Letter
    ZDB-ID 269-0
    ISSN 1528-1175 ; 0003-3022
    ISSN (online) 1528-1175
    ISSN 0003-3022
    DOI 10.1097/ALN.0000000000000584
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Effector cells of anaphylaxis: mast cells and basophils.

    Schwartz, Lawrence B

    Novartis Foundation symposium

    2004  Band 257, Seite(n) 65–74; discussion 74–9, 98–100, 276–85

    Abstract: Systemic anaphylaxis arises when mast cells, possibly along with other cell types, are provoked to secrete mediators that evoke a systemic response. Mast cells in perivascular, respiratory, gastrointestinal and cutaneous tissues are likely involved, ... ...

    Abstract Systemic anaphylaxis arises when mast cells, possibly along with other cell types, are provoked to secrete mediators that evoke a systemic response. Mast cells in perivascular, respiratory, gastrointestinal and cutaneous tissues are likely involved, regardless of whether IgE or non-IgE-dependent pathways are invoked. Alpha/beta tryptases are selectively and abundantly produced by mast cells. Tryptase levels in the circulation provide a precise indicator of mast cell involvement. Mature beta tryptase is stored in secretory granules and is released when the cells are activated to degranulate, as occurs in anaphylaxis. Alpha/beta pro/pro' tryptases are spontaneously secreted by mast cells. Consequently, mature tryptase levels in serum (normally 1 ng/ml) are elevated in systemic anaphylaxis. Total tryptase levels (mature plus precursor forms), normally 1-15 ng/ml in baseline serum samples, are elevated in patients with systemic mastocytosis (> 20 ng/ml), a disease that also predisposes one to anaphylactic reactions. The assessment of basophils in systemic anaphylactic reactions has been problematic, because an assay for a specific releasable marker from this cell type has not been developed. Nevertheless, in cases of anaphylaxis in which elevations of histamine, but not tryptase, have been detected, it is enticing to speculate that basophil-dependent anaphylaxis may have occurred.
    Mesh-Begriff(e) Allergens/immunology ; Anaphylaxis/blood ; Anaphylaxis/epidemiology ; Anaphylaxis/immunology ; Anaphylaxis/physiopathology ; Autoimmunity/physiology ; Basophils/immunology ; Biomarkers ; Diagnosis, Differential ; Humans ; Inflammation Mediators/blood ; Inflammation Mediators/immunology ; Isoenzymes/blood ; Isoenzymes/genetics ; Isoenzymes/immunology ; Mast Cells/enzymology ; Mast Cells/immunology ; Mastocytosis, Systemic/immunology ; Serine Endopeptidases/blood ; Serine Endopeptidases/genetics ; Serine Endopeptidases/immunology ; Tryptases
    Chemische Substanzen Allergens ; Biomarkers ; Inflammation Mediators ; Isoenzymes ; Serine Endopeptidases (EC 3.4.21.-) ; Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2004
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ISSN 1528-2511
    ISSN 1528-2511
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Chronic Idiopathic Urticaria: Systemic Complaints and Their Relationship with Disease and Immune Measures

    Doong, Judy C. / Chichester, Kris / Oliver, Eric T. / Schwartz, Lawrence B. / Saini, Sarbjit S.

    The Journal of Allergy and Clinical Immunology: In Practice. 2017,

    2017  

    Abstract: Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) sometimes report systemic complaints (SC).We sought to determine the frequency and characteristics of SC among CIU patients, as well as the association of SC with disease measures, basophil ...

    Abstract Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) sometimes report systemic complaints (SC).We sought to determine the frequency and characteristics of SC among CIU patients, as well as the association of SC with disease measures, basophil histamine release, and serum tryptase.Adult CIU patients were recruited from a university allergy clinic. Patients completed a disease symptom survey and underwent blood sampling for subsequent basophil histamine release and serum tryptase measurement.A total of 155 CIU patients were surveyed, with 103 reporting SC with concomitant hives as follows: joint pain or swelling (55.3%), headache/fatigue (47.6%), flushing (42.7%), wheezing (30.1%), gastrointestinal complaints (26.2%), and palpitations (9.7%). Patients with SC (CIU-SC) were compared to those without (CIU-NSC). Both groups had similar demographics (average age in 40s, majority female and Caucasian) and basophil histamine release profiles. CIU-SC had significantly greater disease duration (51.5% CIU-SC vs 30.8% CIU-NSC had >4 years duration), emergency department (ED) visits (41.7% vs 23.1% had >1 visit in the last year), CIU-related work absences (65% vs 27.5% had >1 day), oral corticosteroids use (84.5% vs 59.6%), quality of life (QoL) impairment (76.1 vs 59.2 SkinDex Score), and serum tryptase (5.1ng/ml vs 3.9ng/ml).Despite similar demographics and basophil profiles as CIU-NSC patients, CIU-SC patients have features of greater disease burden (work absences, ED visits, and corticosteroid use), QoL impairment, and baseline serum tryptase levels.
    Schlagwörter Chronic idiopathic urticaria ; chronic spontaneous urticaria ; systemic complaints ; tryptase ; histamine ; quality of life ; CIU ; CSU ; SC ; NSC ; ED ; QoL ; HR ; USS
    Sprache Englisch
    Erscheinungsort Elsevier Inc.
    Dokumenttyp Artikel ; Online
    Anmerkung Pre-press version
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2016.11.037
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang